Australian wins prize for vaccine; 1918 epidemic may be key to preventing new outbreaks;

Vaccine Research

Australia's Ian Frazer has won the $800,000 International Balzan Prize for his work developing a cervical cancer vaccine. Report

Researchers at Vanderbilt University Medical Center have been working with the antibodies from survivors of the deadly 1918 flu epidemic as they work to develop new vaccines to prevent future outbreaks. Story

The National Institute of Allergy and Infectious Diseases has forged a collaboration with Nabi to advance the company's PentaStaph vaccine S. aureus infections in the community and hospital settings. Nabi release

St. Louis University School of Medicine will help test new combinations of vaccines in 500 people to see if the body can build resistance to the dangerous bird flu virus. Report

A Ugandan university has received $450,000 to test a new malaria vaccine. Report

A British group has begun recruiting volunteers for a new bird flu vaccine trial. Report

Vaccine Market

Health officials are already beating the drum to get people lined up for their fall flu jab. They are keeping their fingers cross that this season's vaccines are better designed than last year's. Report

China's Sinovac Biotech has launched Anflu, a seasonal influenza vaccine, for the upcoming flu season.  Sinovac release

There's new data to suggest that the newborn intensive care unit is a good place to offer parents of high-risk infants the tetanus, diphtheria, and acellular pertussis vaccine. Report

Suggested Articles

Ebola has claimed thousands of lives in recent outbreaks, but now the world has a licensed vaccine option in Merck's Ervebo.

Cosette Pharmaceuticals which was formed in December with a deal for dermatology projects has gone back to G&W Labs for a liquids plant.

Takeda has spent considerable resources on its phase 3 dengue vaccine, and now data show the shot was 80% effective in preventing dengue.